Switch decisions are high-stakes and often rushed. A data-first escalation framework protects you from changing therapy based on noisy snapshots.
TL;DR
- Do not escalate without clear trend evidence.
- Audit adherence and setup quality before concluding failure.
- Use clinician discussion with documented logs.
- Track post-switch windows with the same protocol.
Important
This article is educational and not medical advice. If you are worried about sudden shedding, scalp symptoms, or side effects, talk to a licensed clinician.
What to track first
- Confirm adherence consistency before escalation.
- Compare at least two decision windows pre-switch.
- Capture side-effect context and confounders.
- Use identical protocol for post-switch interpretation.
Decision checklist
- Was baseline quality high enough to support escalation?
- Are worsening signals persistent and reproducible?
- Have confounders been ruled out?
- Is clinician guidance integrated into decision timing?
Track-first next step
Start with a clean baseline and compare weekly captures in 4-8 week windows before changing your routine. Use the start path if you need the fastest way to build a reliable baseline.
Related reading
- Dutasteride vs finasteride framework
- Finasteride side effects tracking
- Treatments guide
- One-variable protocol
Sources: PubMed: dutasteride vs finasteride meta-analysis and MedlinePlus: finasteride.
